Atlas Trials

Glutamate Inhibitors in Glioblastoma

Clinical trial NCT05664464 · RECRUITING

Trial details

NCT number
NCT05664464
Sponsor
University of Zurich
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2023-01-01
Primary completion
2026-06-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.